The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Gastrodenol     bismuth;3-carboxy-3,5- dihydroxy-5-oxo...

Synonyms: De-Noltab, LS-121079, AKOS015918338, FT-0623129, AC1O3RM9, ...
This record was replaced with 311.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of citric acid


High impact information on citric acid


Chemical compound and disease context of citric acid


Biological context of citric acid


Anatomical context of citric acid


Associations of citric acid with other chemical compounds


Gene context of citric acid


Analytical, diagnostic and therapeutic context of citric acid


  1. Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine. Bianchi Porro, G., Lazzaroni, M., Petrillo, M., De Nicola, C. Lancet (1984) [Pubmed]
  2. Campylobacter pylori in abattoir workers: is it a zoonosis? Vaira, D., D'Anastasio, C., Holton, J., Dowsett, J.F., Londei, M., Bertoni, F., Beltrandi, E., Grauenfels, P., Salmon, P.R., Gandolfi, L. Lancet (1988) [Pubmed]
  3. Acute renal failure after colloidal bismuth subcitrate overdose. Taylor, E.G., Klenerman, P. Lancet (1990) [Pubmed]
  4. Effect of Helicobacter pylori infection on colloidal bismuth subcitrate concentration in gastric mucus. Muñoz, D.J., Tasman-Jones, C., Pybus, J. Gut (1992) [Pubmed]
  5. Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial. Humphreys, H., Bourke, S., Dooley, C., McKenna, D., Power, B., Keane, C.T., Sweeney, E.C., O'Moráin, C. Gut (1988) [Pubmed]
  6. Acute renal failure after overdose of colloidal bismuth subcitrate. Huwez, F., Pall, A., Lyons, D., Stewart, M.J. Lancet (1992) [Pubmed]
  7. Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine. Pan, S.A., Liao, C.H., Lien, G.S., Chen, S.H. Gastroenterology (1991) [Pubmed]
  8. Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment. Tsai, H.H., Dwarakanath, A.D., Hart, C.A., Milton, J.D., Rhodes, J.M. Gut (1995) [Pubmed]
  9. Effect of colloidal bismuth subcitrate on age related gastric lesions in the rat. Hinsull, S.M. Gut (1991) [Pubmed]
  10. Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol). Baron, J.H., Barr, J., Batten, J., Sidebotham, R., Spencer, J. Gut (1986) [Pubmed]
  11. Implications of sucralfate-induced ulcer healing and relapse. Lam, S.K. Am. J. Med. (1989) [Pubmed]
  12. Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer. Sheu, B.S., Yang, H.B., Su, I.J., Shiesh, S.C., Chi, C.H., Lin, X.Z. Gastrointest. Endosc. (1996) [Pubmed]
  13. Selection of patients for treatment of duodenal ulcer infected with Helicobacter pylori. Neeman, A., Kadish, U. J. Clin. Gastroenterol. (1994) [Pubmed]
  14. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate. Bianchi Porro, G., Parente, F. J. Clin. Gastroenterol. (1992) [Pubmed]
  15. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study. Kang, J.Y., Tay, H.H., Wee, A., Guan, R., Math, M.V., Yap, I. Gut (1990) [Pubmed]
  16. Plasma and tissue distribution of bismuth in normal and cirrhotic rats. Luppino, M.A., McLean, A.J. The Analyst. (1995) [Pubmed]
  17. Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate. Froomes, P.R., Wan, A.T., Keech, A.C., McNeil, J.J., McLean, A.J. Eur. J. Clin. Pharmacol. (1989) [Pubmed]
  18. Colloidal bismuth subcitrate-induced changes on gastric mucosal hemodynamics in the rat: gastric mucosal blood flow after CBS treatment. Eleftheriadis, E., Kotzampassi, K., Tzartinoglou, E., Salem, A., Aletras, H. Gastroenterol. Jpn. (1991) [Pubmed]
  19. A novel means of comparing the bioequivalence of two formulations of tripotassium dicitrato bismuthate (De-Noltab). Coghill, S.B., Shepherd, A.N. Postgraduate medical journal. (1988) [Pubmed]
  20. Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori. Rokkas, T., Pursey, C., Uzoechina, E., Dorrington, L., Simmons, N.A., Filipe, M.I., Sladen, G.E. Gut (1988) [Pubmed]
  21. Uptake and subcellular localisation of bismuth in the gastrointestinal mucosa of rats after short term administration of colloidal bismuth subcitrate. Stiel, D., Murray, D.J., Peters, T.J. Gut (1985) [Pubmed]
  22. Effect of bismuth subcitrate and sucralfate on rat duodenal and human gastric bicarbonate secretion in vivo. Shorrock, C.J., Garner, A., Hunter, A.H., Crampton, J.R., Rees, W.D. Gut (1990) [Pubmed]
  23. Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: a 12-month follow-up study. Chen, T.S., Tsay, S.H., Chang, F.Y., Lee, S.D. Am. J. Gastroenterol. (1994) [Pubmed]
  24. Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists. Tytgat, G.N., Lamers, C.B., Hameeteman, W., Jansen, J.M., Wilson, J.A. Aliment. Pharmacol. Ther. (1987) [Pubmed]
  25. Evaluation of treatment regimens to cure Helicobacter pylori infection--a meta-analysis. Laheij, R.J., Rossum, L.G., Jansen, J.B., Straatman, H., Verbeek, A.L. Aliment. Pharmacol. Ther. (1999) [Pubmed]
  26. Solubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy. Phillips, R.H., Whitehead, M.W., Lacey, S., Champion, M., Thompson, R.P., Powell, J.J. Helicobacter (2000) [Pubmed]
  27. Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy. Lerang, F., Moum, B., Haug, J.B., Berge, T., Tolås, P., Sandvei, P.K., Torp, R., Tønnesen, T. Scand. J. Gastroenterol. (1997) [Pubmed]
  28. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. O'Riordan, T., Mathai, E., Tobin, E., McKenna, D., Keane, C., Sweeney, E., O'Morain, C. Gut (1990) [Pubmed]
  29. Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats. Konturek, S.J., Dembinski, A., Warzecha, Z., Bielanski, W., Brzozowski, T., Drozdowicz, D. Gut (1988) [Pubmed]
  30. Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro. Slomiany, B.L., Nishikawa, H., Bilski, J., Slomiany, A. Am. J. Gastroenterol. (1990) [Pubmed]
  31. Enhancement in gastric mucus gel qualities with colloidal bismuth subcitrate administration. Piotrowski, J., Bilski, J., Nishikawa, H., Slomiany, A., Slomiany, B.L. Eur. J. Pharmacol. (1990) [Pubmed]
  32. Development of a 14C-urea breath test in ferrets colonised with Helicobacter mustelae: effects of treatment with bismuth, antibiotics, and urease inhibitors. McColm, A.A., Bagshaw, J.A., O'Malley, C.F. Gut (1993) [Pubmed]
  33. 14C-urea breath test in C pylori gastritis. Rauws, E.A., Royen, E.A., Langenberg, W., Woensel, J.V., Vrij, A.A., Tytgat, G.N. Gut (1989) [Pubmed]
  34. Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection. Dore, M.P., Graham, D.Y., Mele, R., Marras, L., Nieddu, S., Manca, A., Realdi, G. Am. J. Gastroenterol. (2002) [Pubmed]
  35. Dosage of colloidal bismuth subcitrate in duodenal ulcer healing and clearance of Campylobacter pylori. Coghlan, J., Hutchinson, L., Gilligan, D., McKenna, D., Keane, C., Sweeney, E., O'Morain, C. Aliment. Pharmacol. Ther. (1990) [Pubmed]
WikiGenes - Universities